Spider toxin inhibits gating pore currents underlying periodic paralysis
- PMID: 29636418
- PMCID: PMC5924911
- DOI: 10.1073/pnas.1720185115
Spider toxin inhibits gating pore currents underlying periodic paralysis
Abstract
Gating pore currents through the voltage-sensing domains (VSDs) of the skeletal muscle voltage-gated sodium channel NaV1.4 underlie hypokalemic periodic paralysis (HypoPP) type 2. Gating modifier toxins target ion channels by modifying the function of the VSDs. We tested the hypothesis that these toxins could function as blockers of the pathogenic gating pore currents. We report that a crab spider toxin Hm-3 from Heriaeus melloteei can inhibit gating pore currents due to mutations affecting the second arginine residue in the S4 helix of VSD-I that we have found in patients with HypoPP and describe here. NMR studies show that Hm-3 partitions into micelles through a hydrophobic cluster formed by aromatic residues and reveal complex formation with VSD-I through electrostatic and hydrophobic interactions with the S3b helix and the S3-S4 extracellular loop. Our data identify VSD-I as a specific binding site for neurotoxins on sodium channels. Gating modifier toxins may constitute useful hits for the treatment of HypoPP.
Keywords: channelopathy; gating modifier; hypokalemic periodic paralysis; neurotoxin; sodium channel.
Copyright © 2018 the Author(s). Published by PNAS.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Suetterlin K, Männikkö R, Hanna MG. Muscle channelopathies: Recent advances in genetics, pathophysiology and therapy. Curr Opin Neurol. 2014;27:583–590. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
